[go: up one dir, main page]

AU1159897A - Analogs of peptide yy and uses thereof - Google Patents

Analogs of peptide yy and uses thereof

Info

Publication number
AU1159897A
AU1159897A AU11598/97A AU1159897A AU1159897A AU 1159897 A AU1159897 A AU 1159897A AU 11598/97 A AU11598/97 A AU 11598/97A AU 1159897 A AU1159897 A AU 1159897A AU 1159897 A AU1159897 A AU 1159897A
Authority
AU
Australia
Prior art keywords
analogs
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11598/97A
Inventor
Ambikaipakan Balasubramaniam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Cincinnati
Original Assignee
CINCINNATI THE, University of
University of Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CINCINNATI THE, University of, University of Cincinnati filed Critical CINCINNATI THE, University of
Publication of AU1159897A publication Critical patent/AU1159897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU11598/97A 1996-11-13 1996-11-13 Analogs of peptide yy and uses thereof Abandoned AU1159897A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/018374 WO1998020885A1 (en) 1996-11-13 1996-11-13 Analogs of peptide yy and uses thereof

Publications (1)

Publication Number Publication Date
AU1159897A true AU1159897A (en) 1998-06-03

Family

ID=22256144

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11598/97A Abandoned AU1159897A (en) 1996-11-13 1996-11-13 Analogs of peptide yy and uses thereof

Country Status (5)

Country Link
EP (1) EP1015007A1 (en)
JP (1) JP2000505105A (en)
AU (1) AU1159897A (en)
CA (1) CA2271788A1 (en)
WO (1) WO1998020885A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
JP2003518914A (en) * 1999-02-10 2003-06-17 キュリス インコーポレイテッド Methods and reagents for treating glucose metabolism disorders
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
DE60230818D1 (en) 2001-09-24 2009-02-26 Imp Innovations Ltd PYY3-36 FOR REDUCING OR PREVENTING GREASE LUBRICITY
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
BR0316685A (en) 2002-12-17 2005-11-01 Nastech Pharm Co Compositions and methods for the improved mucosal administration of γ2 receptor-fixing peptides and methods for treating and preventing obesity
WO2004066966A2 (en) 2003-01-17 2004-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide yy analogs
EP1789440A4 (en) * 2004-02-11 2008-03-12 Amylin Pharmaceuticals Inc PANCREAS POLYPEPTIDE FAMILY MOTIVES AND POLYPEPTIDES CONTAINING THEM
MXPA06013252A (en) 2004-05-14 2007-02-28 Emisphere Tech Inc Compounds and compositions for delivering active agents.
EP1745004B8 (en) 2004-05-14 2016-07-27 Emisphere Technologies, Inc. Aryl ketone compounds and compositions for delivering active agents
MX2007006830A (en) 2004-12-13 2008-02-07 Amylin Pharmaceuticals Inc Pancreatic polypeptide family motifs, polypeptides and methods comprising the same.
EA014647B1 (en) 2005-08-11 2010-12-30 Амилин Фармасьютикалз, Инк. Hybrid polypeptides with selectable properties
TWI428346B (en) 2006-12-13 2014-03-01 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
RS56998B1 (en) 2010-12-16 2018-05-31 Novo Nordisk As Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
CN104203266B (en) 2012-03-22 2017-12-26 诺和诺德股份有限公司 GLP-1 peptide composition and its preparation
RU2671406C2 (en) 2013-05-02 2018-10-31 Ново Нордиск А/С Oral dosing of glucagon-like peptide-1 compounds
US10583172B2 (en) 2013-11-15 2020-03-10 Novo Nordisk A/S HPYY(1-36) having a beta-homoarginine substitution at position 35
AU2014350197B2 (en) 2013-11-15 2018-10-04 Novo Nordisk A/S Selective PYY compounds and uses thereof
CN107849110B (en) 2015-06-12 2021-11-26 诺和诺德股份有限公司 Selective PYY compounds and uses thereof
BR112020014624A2 (en) 2018-02-02 2020-12-08 Novo Nordisk A/S SOLID COMPOSITIONS UNDERSTANDING GLP-1 AGONIST, CAPRILIC AND LUBRICANT N- (8- (2-HYDROXYBENZOIL) AMINO ACID SALT)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026685A (en) * 1988-07-15 1991-06-25 The Salk Institute For Biological Studies NPY peptide analogs
US5328899A (en) * 1988-07-15 1994-07-12 The Salk Institute For Biological Studies NPY peptide analogs

Also Published As

Publication number Publication date
WO1998020885A1 (en) 1998-05-22
JP2000505105A (en) 2000-04-25
EP1015007A1 (en) 2000-07-05
CA2271788A1 (en) 1998-05-22

Similar Documents

Publication Publication Date Title
HU9502833D0 (en) Analogs of peptide yy and uses thereof
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU1159897A (en) Analogs of peptide yy and uses thereof
AU4230196A (en) Treatment of pancreatic tumors with peptide yy and analogs thereof
AU692612B2 (en) Peptide mixture and products thereof
AU3574897A (en) Aqueous formulations of peptides
IL128529A0 (en) Anti-inflammatory peptides and uses thereof
AU5893696A (en) Modification of polypeptides
EP0785276A4 (en) Modification of peptide and protein
AU5893796A (en) Modification of polypeptides
AU2548097A (en) Formulations of ob protein
AU1884397A (en) Antifungic and antibacterial peptide
AU2972097A (en) Peptide derivatives
AU1731997A (en) Antipathogenic peptides and compositions comprising them
AU2526497A (en) Post-labeling stabilization of radiolabeled proteins and peptides
AU4463996A (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU2091799A (en) Uses of alpha-conotoxin peptides
AU1803597A (en) Peptide derivatives
AU4427296A (en) Novel peptide
AU4905497A (en) Antimicrobial peptide analogs of gramicidin s and compositions comprising them
AU4074997A (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
AU2054797A (en) Isolated human herpesvirus type 8 sequences and uses thereof
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
AU4236097A (en) Mhc peptides and methods of use
AU3118297A (en) Sok-1 and methods of use